Skip to main content
. 2023 Aug 30;41(2):81–108. doi: 10.1097/EJA.0000000000001876
Recommendation 3.4 Quality of the evidence Strength of recommendation
We do not suggest using biomarkers to identify patients at risk of POD. Low (References in the Supplement Table S9) Weak